Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImmupharma Share News (IMM)

Share Price Information for Immupharma (IMM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.075
Bid: 1.80
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.35 (19.444%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2.075
IMM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MORNING BRIEFING: AB Foods Lifted To Buy From Sell By Goldman

Fri, 29th May 2015 07:28

LONDON (Alliance News) - Share prices have opened flat to marginally higher Friday, as concerns about Greek debt continue to weigh on market sentiment.

Associated British Foods is leading FTSE 100 gainers, up 3.7%, after being raised straight to Buy from Sell by Goldman Sachs.

However, most of the company news has concerned FTSE 250 companies, with M&A announcements from TeleCity, Synergy Health and Carillion.

Here is what you need to know at the London market open:
----------
MARKETS
----------
FTSE 100: up 0.1% at 7,048.03
FTSE 250: flat at 18,239.73
AIM ALL-SHARE: flat at 770.00
----------
Hang Seng: up 0.1% at 27,482.68
Nikkei 225: closed up 0.1% at 20,563.15
DJIA: closed down 0.2% at 18,126.12
S&P 500: closed down 0.1% at 2,120.79
----------
GBP: down at USD1.5288
EUR: down at USD1.0937

GOLD: flat at USD1,188.57 per ounce
OIL (Brent): up at USD62.81 a barrel

(changes since end of previous GMT day)
----------
ECONOMICS AND GENERAL
----------
Friday's Key Economic Events still to come
(all times in BST)

09:00 Italy Gross Domestic Product
09:00 EU M3 Money Supply and Private loans
10:00 Italy Consumer Price Index
11:00 Italy Producer Price Index
13:30 US Gross Domestic Product
13:30 US Personal Consumption Expenditures
13:30 Canada Gross Domestic Product
14:45 US Chicago Purchasing Managers' Index
15:00 US Reuters/Michigan Consumer Sentiment Index
----------
An index measuring consumer confidence in the UK decreased in May, after a 12-year high in the previous month, as all five measures contributed negatively to the index, the latest survey from GfK showed on Friday. The consumer confidence index fell 3 points to +1 from +4. Economists had expected the index to remain at +4.
----------
A meeting of the world's leading financial officials in Dresden enters its final day on Friday with the Greek debt crisis set to again top the talks. The finance ministers and central bankers of the Group of Seven major industrial nations meeting in the eastern German city will also focus on steps to ease the debt burden facing Ukraine, as well as measures to head off the financing of terrorist groups. The move on terrorist groups comes in the wake of evidence that the Islamic State militants have managed to build up a big war chest of funds as part of their drive to forge a caliphate in Syria and Iraq. While not on the Dresden meeting's formal agenda, the Greek crisis is expected to form part of the discussions at Friday's working session.
----------
International Monetary Fund chief Christine Lagarde no longer rules out Greece exiting the eurozone. "Greece's exit is a possibility," Lagarde told Germany's daily Frankfurter Allgemeine Zeitung in an interview published on the newspaper's website on Thursday. The IMF chief says that such a move would not be easy but would "probably not mean the end of the euro." Lagarde added: "It is very unlikely that we will reach a comprehensive solution in the next few days."
----------
British Prime Minister David Cameron met Dutch and French leaders Thursday as he began a Europe-wide trip to drum up support for EU reforms in the face of strong opposition from some of the continent's major powers. "My priority is to make the EU more competitive, while also doing what's best for Britain," Cameron said in Paris after meeting with French President Francois Hollande. While the premier was travelling, Foreign Secretary Philip Hammond introduced the EU Referendum Bill to the British parliament, confirming plans to hold a referendum before the end of 2017 on whether Britain should remain a member of the EU.
----------
France's household consumption grew less-than-expected in April after a slump in March, amid weaker spending on durables, figures from the statistical office INSEE showed. Household consumption edged up 0.1% from March, when it declined 0.7%, which was the biggest fall since January 2014. Economists had forecast 0.4% growth.
----------
Consumer prices in Japan increased at a slower rate in April compared to the previous month, the Ministry of Internal Affairs and Communications said. The consumer price index were up 0.6% on year in April, slower than the previous month's 2.3 growth. Core inflation, which strips out the volatile costs of food, advanced 0.3%, slower than the previous month's 2.2% increase.
----------
Japan's unemployment rate dropped unexpectedly to a 18-year low in April, the Ministry of Communications and Internal Affairs said. The jobless rate came in at a seasonally adjusted 3.3% in April, down slightly from 3.4% in the previous month. Economists had expected the rate to remain stable at 3.4%.
----------
Industrial output in Japan increased as expected in April, after declining in the previous two months, preliminary figures from the Ministry of Economy, Trade and Industry showed Thursday. Industrial production climbed a seasonally adjusted 1.0% month-over-month in April, in line with expectations, reversing a 0.8% fall in March. It was the first increase in three months.
----------
Beleaguered president Joseph Blatter opened the 65th FIFA congress on Thursday - after crisis meetings and being told by European football boss Michel Platini to step down from the top job at the world ruling body. Platini said that UEFA will attend the congress, despite an earlier boycott threat, and that most of its members supported Blatter's challenger, Jordan's Prince Ali Bin al-Hussein, in Friday's FIFA presidential election. Sponsors increased pressure on FIFA and its president while Olympic supremo Thomas Bach urged FIFA to follow their example toward reform.
----------
BROKER RATING CHANGES
---------
GOLDMAN RAISES AB FOODS TO 'BUY' ('SELL') - TARGET 3120 (2755) PENCE
----------
GOLDMAN RESUMES AVIVA WITH 'BUY' - TARGET 610 PENCE
----------
BARCLAYS RAISES OPHIR ENERGY TO 'OVERWEIGHT' ('EQUAL WEIGHT')
----------
COMPANIES - FTSE 100
----------
Life insurance and asset management group Old Mutual said it has agreed a deal to sell the Swiss arm of its Skandia business for an undisclosed amount. The Anglo-South African group said Skandia Leben, part of its Old Mutual Wealth division, has been sold to Life Invest Holding, a company formed by the German conglomerate Mutschler Group and Hannover Re, the German reinsurer.
----------
British Land said that it and its partner Oxford Properties have completed three lettings deals at the Leadenhall Building in the City of London. British Land said the lettings at the building, known as the Cheesegrater, have been made with insurer Brit, Spanish banking group Banco Sabadell and investment manager Kames Capital. The building is now 84% let. Banco Sabadell is in the process of buying TSB Banking Group.
----------
The Royal Bank of Scotland Group is preparing for the UK government to start offloading shares in the lender by inviting investment banks to pitch for an enlarged corporate broking role, the Financial Times reported. RBS is inviting pitches from banks for an expanded corporate broking role which would include acting as privatisation advisers. Senior figures at the bank told the FT that the government could launch the share sale in the fourth quarter of 2015 after RBS closes a settlement with US regulators over the mis-selling of sub-prime mortgage securities. The UK government still owns about 80% of RBS after injecting it with GBP45 billion to prevent the bank from failing at the height of the financial crisis.
----------
Aer Lingus Group and International Consolidated Airlines Group late Thursday welcomed the decision by the Irish government - the Dáil - to approve the sale of its shareholding in Aer Lingus to IAG. The Irish government gave its backing to IAG's EUR1.4 billion offer for Aer Lingus on Tuesday. The other obstacle IAG still has to overcome is securing the support of Ryanair Holdings, the budget carrier which holds a 29.8% stake in Aer Lingus.
----------
COMPANIES - FTSE 250
----------
Construction and support services company Carillion said it has acquired Canadian remote-site accommodation and services business Outland Group for up to GBP63 million in cash in order to boost its operations in Canada.
----------
TeleCity Group said it agreed terms on a GBP2.35 billion cash and share takeover offer from US peer Equinix, and terminated its previous deal to acquire Dutch data centre company Interxion Holding.
Under the terms of the deal TeleCity shareholders will receive 572.5 pence in cash and 0.0327 shares in the new company per share, which values each TeleCity share at 1,145.0 pence. Following the completion of the takeover, TeleCity shareholders will hold around 10.1% of the combined company.
----------
Synergy Health and STERIS said they intend to contest the US Federal Trade Commission's attempt to block STERIS's proposed USD1.9 billion cash and share takeover of Synergy Health. The FTC has informed Synergy that it intends to seek to block the acquisition. STERIS and Synergy said in a statement that they welcome "a full judicial review of the competitive effects of the combination".
----------
Banco Sabadell and TSB Banking Group said they have extended the offer timetable on the Spanish bank's bid for the UK lender. Banco Sabadell agreed a deal in March to acquire TSB for GBP1.7 billion and has secured the backing of key shareholder Lloyds Banking Group. On Friday, Sabadell said the deal remain conditional on the Prudential Regulation Authority in the UK approving a change of control of TSB. Sabadell said the talks are progressing well but said it has agreed that, owing to the regulatory timetable, that the latest date the offer can be declared unconditional has been extended to July 7.
----------
COMPANIES - LONDON MAIN MARKET AND AIM
----------
Oil and gas explorer Afren said it has secured a higher-than-anticipated funding commitment from its noteholders, as it said revenue and its operating cash flow in the first quarter of 2015 dropped sharply year-on-year. Afren said that holders of its 2016, 2019 and 2020 nots have agreed to subscribe for new senior notes up to the maximum permitted level of USD369 million, USD93 million more than the company had announced it would received in net cash proceeds at the end of April. Afren also said revenue in the first quarter to the end of March was down sharply to USD103.3 million from USD269 million a year earlier, with its operating cash flow prior to working capital movements down to GBP59.1 million from GBP169.1 million.
----------
Entu said it has appointed Geoff Stevens as chief financial officer effective from June 1. The home improvement group, which provides energy efficiency products and services, said that Stevens has worked as CFO in a variety of companies, most recently at John Brown Media Group and Protocol Group.
----------
Immunodiagnostic Systems Holdings said it expects revenue to continue to fall in its current year, and revenue in its recently ended financial year to be in line with previous guidance. The company, which provides clinical laboratory diagnostic services, expects to post revenue of GBP45 million for the year to end-March 2015, compared to GBP52 million a year before. It expects revenue to fall further in its current year to end-March 2016 to a range between GBP39 million and GBP42 million.
----------
Circle Oil said it has poached Mitchell Flegg from fellow AIM-listed oil and gas firm Serica Energy to be its new chief executive. Flegg will join the company on June 1 and moves from his role as chief operating officer at Serica. Serica didn't say if or how Flegg will be replaced.
----------
COMPANIES - INTERNATIONAL
----------
Chip maker Intel is close to a deal to buy programmable chip maker Altera for about USD15 billion, the New York Post reported.
----------
Financial services giant JPMorgan Chase & Co plans to cut more than 5,000 jobs as part of its efforts to cut down on costs and boost efficiency, the Wall Street Journal reported Thursday, citing people familiar with the company's decision. According to the WSJ report, JPMorgan has already initiated the job cuts and will cut at least 2% of its workforce over the next year. About 1,000 of the 5,000 job cuts have reportedly been carried out.
----------
The French biotech company Cellectis is in talks about its potential sale, with Pfizer of the US believed to be among the buyers, the Financial Times reported citing people familiar with matter. The report indicated Cellectis was in negotiations over a deal but warned that no outcome was certain. One person said Pfizer had informally approached the company about a deal that could value the target at as much as EUR1.5 billion.
----------
Defective airbags made by Japanese manufacturer Takata have forced Fiat Chrysler to recall 5.2 million cars worldwide, the company said. The company was just one of several automakers that added more cars to existing recalls, news reports said. Fiat Chrysler expanded its previous recall for driver-side Takata airbags by 1.8 million vehicles, Automotive News said.
----------
Google unveiled a new payment service and also security upgrades to its Android software, as the tech giant takes on rivals like Apple. At its annual developers' conference in San Francisco, Google unveiled Android M, the new version of its mobile software, and which will include Android Pay. Android Pay allows users of mobile phones equipped with Google's mobile operating system, Android, to upload credit or debit card to a mobile wallet on their phone.
----------
Friday's Scheduled AGMs/EGMs

Flying Brands
Richland Resources
Shanta Gold
Immupharma
Lookers
Tekcapital
----------
By Tom Waite; thomaslwaite@alliancenews.com; @thomaslwaite

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
2 Apr 2024 12:52

Immupharma jumps amid new IP strategy for P140 technology platform

(Alliance News) - Immupharma PLC on Tuesday announced a new intellectual property strategy to significantly enhance the patent life and commercial value for its P140 technology platform.

Read more
25 Mar 2024 12:20

Incanthera says first order from skincare deal doubles

(Alliance News) - ImmuPharma PLC on Monday noted updates on Incanthera PLC's commercial skincare deal with Marionnaud, which was first announced in December 2023.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 10:55

AIM WINNERS & LOSERS: ImmuPharma order doubles; Aeorema swings to loss

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
6 Mar 2024 13:05

EARNINGS AND TRADING: Challenger signs farm-out; Ricardo revenue up

(Alliance News) - The following is a round-up of earnings and trading updates of London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
19 Dec 2023 17:52

EARNINGS AND TRADING: Time Finance revenue up; Libertine loss narrows

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
18 Dec 2023 12:18

IN BRIEF: Incanthera signs skincare stocking deal, raises GBP1 million

Incanthera PLC - develops technologies in dermatology and oncology - Raises GBP1.0 million in equity to support a deal that will see a major retailer stock Incanthera's 'Skin + Cell' range of skincare products. Raises GBP800,000 from the subscription to 11.4 million new shares at 7 pence each by new and existing institutional investors. At the same price, the University of Bradford converts GBP200,000 that is owed to it by Incanthera into 2.9 million new shares. The university, a founding shareholder in Incanthera, will own 11.2% of the enlarged share capital, with all the newly issued shares representing 15.5% of this. Incanthera also grants warrants to advisers to subscribe for another 800,000 new shares at the same price of 7p over the next 10 years. ImmuPharma PLC, which currently has a 12.7% stake in Incanthera, says it is "delighted" with the announcement of the skincare deal and successful fundraise.

Read more
7 Sep 2023 17:07

TRADING UPDATES: RA International loss narrows as revenue grows

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
31 Aug 2023 13:05

ImmuPharma launches GBP2 million fund raise as interim loss narrows

(Alliance News) - ImmuPharma PLC on Thursday announced a share placing and a retail share offer to raise just under GBP2 million, while it also reported a narrowed loss in the first half of the year on reduced expenses.

Read more
21 Aug 2023 12:33

ImmuPharma agrees 12 month extension to Incanthera warrant instrument

(Alliance News) - Incanthera PLC and ImmuPharma PLC on Monday agreed a 12 month extension to their warrant instrument.

Read more
23 Jun 2023 15:51

UK shareholder meetings calendar - next 7 days

Monday 26 June 
Aterian PLCAGM
Capricorn Energy PLCAGM
Corre Energy BVAGM
Facilities by ADF PLCAGM
Lexington Gold LtdSGM re proposed acquisition of White Rivers Exploration Ltd
LifeSafe Holdings PLCAGM
Premier African Minerals LtdAGM
Vast Resources PLCGM re issuing new share capital
Volvere PLCAGM
Tuesday 27 June 
Acuity RM Group PLCAGM
Comptoir Group PLCAGM
Creo Medical Group PLCAGM
First Tin PLCAGM
Forward Partners Group PLCAGM
Galantas Gold CorpAGM
Gemfields Group LtdAGM
Golden Prospect Precious Metals LtdAGM
Hamak Gold LtdAGM
ICG Enterprise Trust PLCAGM
Impellam Group PLCAGM
India Capital Growth Fund LtdAGM
Inspiration Healthcare Group PLCAGM
Instem PLCAGM
JD Sports Fashion PLCAGM
Kingfisher PLCAGM
Mercantile Ports & Logistics LtdGM re equity fundraising
Mobile Tornado Group PLCAGM
Revolution Beauty Group PLCAGM
Scottish Mortgage Investment Trust PLCAGM
Serabi Gold PLCAGM
Sondrel Holdings PLCAGM
Surface Transforms PLCAGM
Surgical Innovations Group PLCAGM
Trinity Exploration & Production PLCAGM
Wednesday 28 June 
Atalaya Mining PLCAGM
Avacta Group PLCAGM
Boku IncAGM
Cambridge Cognition Holdings PLCAGM
Cizzle Biotechnology Holdings PLCAGM
Cobra Resources PLCAGM
Cora Gold LtdAGM
Dial Square Investments PLCAGM
Itaconix PLCAGM
NB Distressed Debt Investment Fund LtdAGM
Panthera Resources PLCGM re directors’ authority to allot shares
Phoenix Spree Deutschland LtdAGM
Pineapple Power Corp PLCAGM
Polarean Imaging PLCAGM
RA International Group PLCAGM
Schroder European Real Estate Investment Trust PLCAGM
Shield Therapeutics PLCAGM
St Mark Homes PLCAGM
Star Phoenix Group LtdAGM
ValiRx PLCAGM
Velocys PLCAGM
Vertu Motors PLCAGM
Warpaint London PLCAGM
Westminster Group PLCAGM
Zenova Group PLCAGM
Thursday 29 June 
3i Group PLCAGM
Africa Opportunity Fund LtdAGM
Anemoi International LtdAGM
Anpario PLCAGM
Ariana Resources PLCAGM
Beowulf Mining PLCAGM
Celadon Pharmaceuticals PLCAGM
Cornish Metals IncAGM
East Imperial PLCAGM
East Star Resources PLCAGM
Eden Research PLCAGM
Engage XR Holdings PLCAGM
First Class Metals PLCAGM
Gresham House Energy Storage Fund PLCGM re remuneration policy
Gusbourne PLCAGM
HeiQ PLCAGM
Helios Underwriting PLCAGM
Ingenta PLCAGM
IQE PLCAGM
Kooth PLCAGM
Landore Resources LtdAGM
Let's Explore Group PLCAGM
Likewise Group PLCAGM
MGC Pharmaceuticals LtdGM re issue of convertible notes
Morgan Advanced Materials PLCAGM
NetScientific PLCAGM
New Century AIM VCT 2AGM
Norman Broadbent PLCAGM
Reabold Resources PLCAGM
Rockhopper Exploration PLCAGM
Roquefort Therapeutics PLCAGM
Serica Energy PLCAGM
SpaceandPeople PLCAGM
Symphony Environmental Technologies PLCAGM
Synairgen PLCAGM
Thalassa Holdings LtdAGM
tinyBuild IncAGM
Touchstone Exploration IncAGM
Trident Royalties PLCAGM
Unigel Group PLCAGM
Verici Dx PLCAGM
Xpediator PLCAGM
Friday 30 June 
Argo Blockchain PLCAGM
Ascent Resources PLCAGM
Bluejay Mining PLCAGM
Caspian Sunrise PLCAGM
Codex Acquisitions PLCAGM
Domino's Pizza Group PLCGM re directors' remuneration policy
Fenikso LtdAGM
Fiinu PLCAGM
FireAngel Safety Technology Group PLCAGM
GENinCode PLCAGM
Hemogenyx Pharmaceuticals PLCAGM
Hiro Metaverse Acquisitions I SAAGM
i3 Energy PLCGM re premium share cancellation
ImmuPharma PLCAGM
Inspired PLCAGM
Jadestone Energy PLCAGM
Kanabo Group PLCAGM
Kefi Gold & Copper PLCAGM
Kistos Holdings PLCAGM
KRM22 PLCAGM
Kropz PLCAGM
LoopUp Group PLCAGM
Medica Group PLCAGM
Mirriad Advertising PLCAGM
Rockfire Resources PLCAGM
Savannah Energy PLCAGM
Strip Tinning Holdings PLCAGM
ThomasLloyd Energy Impact Trust PLCAGM
URA Holdings PLCAGM
World Chess PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
19 Jun 2023 12:02

IN BRIEF: ImmuPharma to start next two phases of Lupuzor trial

ImmuPharma PLC - London-based drug discovery and development company - Will start phases two and three of the clinical trial for Lupuzor in the seocnd half of 2023, following talks with the US Food & Drug Administration. Says the clinical trial will be supported by Avion Pharmaceuticals. Adds further details of the trial will be shared at a later stage. Lupuzor, or P140, is a potential treatment for Lupus disease.

Read more
18 May 2023 12:12

IN BRIEF: ImmuPharma rises on FDA feedback for neurological disease

ImmuPharma PLC - London-based drug discovery and development company - Gets positive support and guidance from the US Food & Drug Administration after a pre-investigational new drug meeting, which confirms the route for a Phase 2/3 adaptive clinical study of P140 in chronic idiopathic demyelinating polyneuropathy. Says the feedback recognises that P140 is suitable to be studied in another disease indication, in addition to systemic lupus erythematosus.

Read more
11 May 2023 11:48

IN BRIEF: ImmuPharma annual loss narrows as R&D spending reduced

ImmuPharma PLC - London-based drug discovery and development company - Posts no revenue for 2022, compared to GBP118,350 for 2021. Pretax loss narrows to GBP4.5 million from GBP8.9 million a year earlier, as operating loss reduces to GBP3.0 million from GBP6.6 million. Research and development expenditure is GBP2.0 million, down from GBP3.7 million in 2021. Chief Executive Officer Tim McCarthy says: "As a board, we remain focused on bringing our two key late stage clinical assets, Lupuzor for lupus and CIDP closer to the market."

Read more
19 Apr 2023 15:40

IN BRIEF: ImmuPharma says US FDA confirms date for Lupuzor meeting

ImmuPharma PLC - London-based drug discovery and development company - Notes the US Food & Drug Administration has set a date of June 7 for a type-C meeting to provide guidance on the phase 2/3 adaptive study of Lupuzor, or P140, in patients with systemic lupus erythematosus, a common type of immune disease lupus. Says this follows the announcement in late March, when it submitted a phase 2/3 clinical trial protocol to the US FDA testing the Lupuzor treatment for lupus patients.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.